Skip to main content
Contact Us
Subscribe
E-Edition
35°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Eliem Therapeutics, Inc.
Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.
October 02, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit
September 11, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Announces Additions to its Leadership Team
August 26, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Reports Second Quarter Financial Results
August 14, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes
June 28, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement
June 27, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement
April 11, 2024
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Announces Plans to Explore Strategic Alternatives
July 20, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights
May 11, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights
March 06, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition
February 09, 2023
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference
November 30, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Reports Third Quarter Financial and Business Highlights
November 14, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics to Participate at Two Upcoming Investor Conferences
November 08, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Eliem Therapeutics Provides Update on Pipeline Progress
October 05, 2022
From
Eliem Therapeutics, Inc.
Via
GlobeNewswire
Tickers
ELYM
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.